Biotechnology

Techseriesinsight > Blog > News > Biotechnology

April 9, 2025
PRNewswire
Biotechnology

ZEISS receives FDA clearance for INTRABEAM 700

As a leading provider of medical solutions in the field of neurosurgery, ZEISS Medical Technology is also dedicated to shaping modern oncology. The company recently received 510(k) clearance from...

April 9, 2025
PRNewswire
Biotechnology

Biomed 2025, Israel’s Leading Annual Life Science Conference and Exhibition, to Take Place May 20-22, in Tel Aviv

Biomed Israel, the premier international Life Science and HealthTech conference in Israel, will take place on May 20-22, 2025 at the David InterContinental Hotel in Tel Aviv, Israel. The event presents a unique...

April 7, 2025
PRNewswire
Biotechnology

Caris Life Sciences Raises $168 Million in Private Capital from Leading Investors to Continue Platform Expansion

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that the company has closed a growth capital funding round of $168 million. With this...

April 7, 2025
PRNewswire
Biotechnology

Viatris Statement on Nationwide Settlement to Resolve Opioid-Related Claims

Viatris Inc. (Nasdaq: VTRS) (the “Company”) today announced it has reached a nationwide settlement framework to resolve opioid-related claims by states, local governments, and Tribes against the Company and certain of...

April 4, 2025
PRNewswire
Biotechnology

Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Sanjay Keswani, M.D., to the company’s executive management team as Chief Medical Officer (CMO) effective June 2, 2025. Dr. Keswani, an accomplished physician-scientist...

April 4, 2025
PRNewswire
Biotechnology

Lundbeck to present positive pipeline data at American Academy of Neurology (AAN) Annual Meeting

H. Lundbeck A/S (Lundbeck) will present positive interim results from the open-label extension of the PACIFIC trial investigating bexicaserin, in addition to new analyses from clinical trials and real-world...

April 3, 2025
PRNewswire
Biotechnology

HALiXPEDITE: Transforming Biologics Therapy Development Programs with Seamless R&D to GMP Integration

HALIX, a leading global healthcare Contract Development and Manufacturing Organization (CDMO), introduces HALiXPEDITE at the Innovation for Health conference in Rotterdam. With the launch of HALiXPEDITE, HALIX introduces a platform...

April 3, 2025
PRNewswire
Biotechnology

UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025

UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS), generalized myasthenia gravis...

April 2, 2025
PRNewswire
Biotechnology

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems, a global leader in anatomic pathology...

April 1, 2025
PRNewswire
Biotechnology

Data Showcasing ALZpath’s Proprietary pTau217 Antibody at AD/PD™ 2025 Demonstrates High Rate of Reliability and Scalability for Alzheimer’s Disease Research and Diagnosis

ALZpath, Inc. (ALZpath), a leading developer of diagnostic tools and solutions for Alzheimer’s disease and related dementias, announced the inclusion of data from evaluation of blood testing platforms utilizing its...